Apply for Cancer Control Grants

The Division of Cancer Control and Population Sciences funds a large portfolio of grants and contracts. The portfolio currently includes over 700 grants, valued at nearly $440 million. Here we provide a listing of funding opportunities that are currently accepting applications. Please visit this page regularly as new funding opportunities are added upon approval by NCI.

For information on the portfolio of over 700 grants, please go to Research Portfolios section of this website.


Filters

Show/Hide Filters
Research Categories

Please check multiple categories. Most funding opportunities are placed in only one category in this table, though parts of them might apply to other categories.

Type of Funding
Activity Code
Type of Research
Title Announcement # / Mechanism(s) Activity Code Clinical Research Expiration Date Program Contact Research Categories Type of Research
Modular R01s in Cancer Control and Population Sciences PAR-18-869 Parent Announcement R01 Clinical Trial Optional March 9, 2021 Scott Rogers
240-276-6932
rogerssc@mail.nih.gov
Parent and Omnibus Funding Announcements Clinical Trials
Cancer Prevention and Control Clinical Trials Grant Program PAR-18-559 Parent Announcement R01 Clinical Trial Required January 8, 2021 Susan Czajkowski
240-276-5871
Susan.Czajkowski@nih.gov
Parent and Omnibus Funding Announcements Clinical Trials
Academic Research Enhancement Award PA-18-343 Parent Announcement R15 Clinical Trial Required January 8, 2021 April Oh
240-276-6709
april.oh@nih.gov
Parent and Omnibus Funding Announcements Clinical Trials
NIH Research Project Grant PA-18-484 Parent Announcement Parent R01 Clinical Trial Not Allowed January 8, 2021 Research Program Contacts Parent and Omnibus Funding Announcements Clinical Trials
NCI Small Grants Program for Cancer Research PAR-18-021 Parent Announcement R03 Clinical Trial Optional January 8, 2020 Research Program Contacts Parent and Omnibus Funding Announcements Clinical Trials
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization PAR-19-352 R01 Clinical Trial Optional September 8, 2022 Michelle Mollica
240-276-7621
mollicama@mail.nih.gov
Cancer Survivorship Clinical Trials
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization PAR-19-355 R21 Clinical Trial Optional September 8, 2022 Michelle Mollica
240-276-7621
mollicama@mail.nih.gov
Cancer Survivorship Clinical Trials
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival PAR-18-893 R01 Clinical Trial Optional September 8, 2021 Frank Perna
240-276-6782
pernafm@mail.nih.gov
Cancer Survivorship, Health Behaviors Research Clinical Trials
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival PAR-18-892 R21 Clinical Trial Optional September 8, 2021 Frank Perna
240-276-6782
pernafm@mail.nih.gov
Cancer Survivorship Clinical Trials
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies PAR-19-325 R01 Clinical Trial Optional February 12, 2022 Kelly Filipski
240-276-6841
Filipskikk@mail.nih.gov
Epidemiology and Genomics Research, Cancer Survivorship Clinical Trial
Geospatial Approaches in Cancer Control and Population Sciences NOT-CA-20-004     January 8, 2022

Armen Ghazarian
240-276-7305
ghazarianaa@mail.nih.gov

April Oh
240-276-6709
ohay@mail.nih.gov

Zaria Tatalovich
240-276-6976
tatalovichzp@mail.nih.gov

Epidemiology and Genomics Research  
Use of Biological Information to Understand How the Interplay of Environmental Exposures and Genes Influences Cancer Risk NOT-CA-20-002 January 8, 2022

Stefanie Nelson
240-276-6944
nelsons@mail.nih.gov

Armen Ghazarian
240-276-7305
ghazarianaa@mail.nih.gov

Epidemiology and Genomics Research Not Clinical Trials
Participant Engagement and Cancer Genome Sequencing (PE-CGS): Research Centers RFA-CA-19-045 U2C Clinical Trial Optional July 31, 2020 Leah Mechanic
240-276-6847
NCI_PE-CGS@mail.nih.gov

Elizabeth Gillanders
240-276-6764
NCI_PE-CGS@mail.nih.gov

Wen-Ying Sylvia Chou

240-276-6954
NCI_PE-CGS@mail.nih.gov
Epidemiology and Genomics Research Clinical Trials
Participant Engagement and Cancer Genome Sequencing (PE-CGS): Coordinating Center RFA-CA-19-046 U24 Clinical Trial Not Allowed July 31, 2020 Leah Mechanic
240-276-6847
NCI_PE-CGS@mail.nih.gov

Elizabeth Gillanders
240-276-6764
NCI_PE-CGS@mail.nih.gov

Wen-Ying Sylvia Chou
240-276-6954
NCI_PE-CGS@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Exploratory Grants in Cancer Epidemiology and Genomics Research PAR-19-277 R21 Clinical Trial Optional October 9, 2021 Mukesh Verma
240-276-6889
vermam@mail.nih.gov
Epidemiology and Genomics Research Clinical Trials
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity PA-19-112 R01 Clinical Trial Optional January 8, 2022 Nonniekaye Shelburne
240-276-6897
nshelburne@mail.nih.gov
Epidemiology and Genomics Research, Cancer Survivorship Clinical Trials
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity PA-19-111 R21 Clinical Trial Optional January 8, 2022 Nonniekaye Shelburne
240-276-6897
nshelburne@mail.nih.gov
Epidemiology and Genomics Research, Cancer Survivorship Clinical Trials
Diet and Physical Activity Assessment Methodology PAR-18-857 R21
Clinical Trial Not Allowed September 8, 2021 Amy Subar
301-594-0831
subara@mail.nih.gov

Richard Troiano
240-276-6916
troianor@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Diet and Physical Activity Assessment Methodology PA-18-856 R01 Clinical Trial Not Allowed September 08, 2021 Amy Subar
301-594-0831
subara@mail.nih.gov

Richard Troiano
240-276-6916
troianor@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression Announcement Numbers PA-18-738 R01 Clinical Trial Optional May 8, 2021 Tram Lam
240-276-6967
lamt@mail.nih.gov
Epidemiology and Genomics Research Clinical Trials
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression Announcement Numbers PA-18-739 R21 Clinical Trial Optional May 8, 2021 Tram Lam
240-276-6967
lamt@mail.nih.gov
Epidemiology and Genomics Research Clinical Trials
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility PA-18-677 R01 Clinical Trial Not Allowed May 8, 2021 Tram Lam
240-276-6967
lamt@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility PA-18-678 R21 Clinical Trial Not Allowed May 8, 2021 Tram Lam
240-276-6967
lamt@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Early-life Factors and Cancer Development Later in Life PA-18-531 R03 Clinical Trial Not Allowed January 8, 2021 Somdat Mahabir
240-276-6941
Mahabir@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Early-life Factors and Cancer Development Later in Life PA-18-529 R01 Clinical Trial Not Allowed January 8, 2021 Somdat Mahabir
240-276-6941
Mahabir@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Early-life Factors and Cancer Development Later in Life PA-18-532 R21 Clinical Trial Not Allowed January 8, 2021 Somdat Mahabir
240-276-6941
Mahabir@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Ethical, Legal, and Social Implications (ELSI) of Genomics Research Grant Program PA-17-444 R01 September 8, 2020 Charlisse Caga-anan
240-276-6738
charlisse.caga-anan@nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors RFA-CA-19-033 U01 Clinical Trial Optional January 4, 2020 Sandra Mitchell
240-276-6929
mitchlls@mail.nih.gov

Danielle Daee
240-276-5744
daeed@mail.nih.gov
Epidemiology and Genomics Research, Cancer Survivorship Clinical Trials
Ethical, Legal, and Social Implications (ELSI) of Genomics Research Grant Program PA-17-446 R21 September 8, 2020 Charlisse Caga-anan
240-276-6738
charlisse.caga-anan@nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Ethical, Legal, and Social Implications (ELSI) of Genomics Research Grant Program PA-17-445 R03 September 8, 2020 Charlisse Caga-anan
240-276-6738
charlisse.caga-anan@nih.gov
Epidemiology and Genomics Research Not Clinical Trials
HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research PAR-17-279 R01 May 8, 2020 Rebecca Liddell Huppi
301-496-4995
liddellr@exchange.nih.gov

Mukesh Verma
240-276-6889
vermam@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research PA-17-278 R21 May 8, 2020 Rebecca Liddell Huppi
301-496-4995
liddellr@exchange.nih.gov

Mukesh Verma
240-276-6889
vermam@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes PA-17-239 R01 May 8, 2020 Melissa Rotunno
240-276-7245
rotunnom@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes PA-17-243 R21 May 8, 2020 Melissa Rotunno
240-276-7245
rotunnom@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts PAR-17-233 U01 May 8, 2020 Joanne Elena
240-276-6818
joanne.elena@nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Genomic Community Resources PAR-17-273 U24 January 26, 2020 Leah Mechanic
240-276-6847
mechanil@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations PA-17-041 R01 January 8, 2020 Tram Lam
240-276-6967
lamt@mail.nih.gov

Damali Martin
240-276-6746
martinda@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations PA-17-042 R21 January 8, 2020 Tram Lam
240-276-6967
lamt@mail.nih.gov

Damali Martin
240-276-6746
martinda@mail.nih.gov
Epidemiology and Genomics Research Not Clinical Trials
NCI's Research Interests to Improve Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatment NOT-CA-19-059 January 8, 2022 Sallie J. Weaver
240-276-6254
sallie.weaver@nih.gov

Veronica Chollette
240-276-6969
cholletv@mail.nih.gov
Healthcare Delivery Research, Cancer Survivorship
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses PAR-19-136 R01 Clinical Trial Optional January 8, 2022 Ashley Wilder Smith
240-276-6714
smithas@mail.nih.gov
Healthcare Delivery Research, Cancer Survivorship Clinical Trials
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses PAR-19-153 R21 Clinical Trial Optional January 8, 2022 Ashley Wilder Smith
240-276-6714
smithas@mail.nih.gov
Healthcare Delivery Research, Cancer Survivorship Clinical Trials
Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations PA-18-932 R01 Clinical Trial Optional January 8, 2022 Erica Breslau
240-276-6773
breslaue@mail.nih.gov
Healthcare Delivery Research Clinical Trials
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer PA-18-492 R21 Clinical Trial Optional May 8, 2021 Gurvaneet Randhawa
240-276-6940
gurvaneet.randhawa@nih.gov
Healthcare Delivery Research, Cancer Survivorship Clinical Trials
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer PA-18-493 R01 Clinical Trial Optional May 8, 2021 Gurvaneet Randhawa
240-276-6940
gurvaneet.randhawa@nih.gov
Healthcare Delivery Research, Cancer Survivorship Clinical Trials
Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests PA-17-495 R01 Clinical Trial Optional January 8, 2021 Erica Breslau
240-276-6773
breslaue@mail.nih.gov
Healthcare Delivery Research Clinical Trials
Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults PA-18-005 R01 Clinical Trial Optional January 8, 2020 Erica Breslau
240-276-6773
breslaue@mail.nih.gov
Healthcare Delivery Research Clinical Trials
Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults PA-18-015  R21 Clinical Trial Optional   January 8, 2020 Erica Breslau
240-276-6773
breslaue@mail.nih.gov
Healthcare Delivery Research Clinical Trials
Palliative Care Needs of Individuals with Rare Advanced Diseases and Their Family Caregivers PA-18-149 R01 Clinical Trial Optional January 8, 2020 Michelle Mollica
240-276-7621
mollicama@mail.nih.gov
Healthcare Delivery Research, Cancer Survivorship Clinical Trials
Palliative Care Needs of Individuals with Rare Advanced Diseases and Their Family Caregivers PA-18-167 R21 Clinical Trial Optional January 8, 2020 Michelle Mollica
240-276-7621
mollicama@mail.nih.gov
Healthcare Delivery Research, Cancer Survivorship Clinical Trials
Research Infrastructure Development for Interdisciplinary Aging Studies PAR-18-645 R21/R33 Clinical Trial Optional January 8, 2020 Erica Breslau
240-276-6773
breslaue@mail.nih.gov
Healthcare Delivery Research Clinical Trials
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies PAR-18-644 R33 Clinical Trial Optional January 8, 2020 Erica Breslau
240-276-6773
breslaue@mail.nih.gov
Healthcare Delivery Research Clinical Trials
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake PAR-19-360 R01 Clinical Trial Optional September 08, 2022 Sarah Kobrin
240-276-6931
kobrins@mail.nih.gov
Healthcare Delivery Research Clinical Trials
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake PAR-19-359 R03 Clinical Trial Optional July 17, 2022 Sarah Kobrin
240-276-6931
kobrins@mail.nih.gov
Healthcare Delivery Research Clinical Trials
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake PAR-19-358 R21 Clinical Trial Optional September 08, 2022 Sarah Kobrin
240-276-6931
kobrins@mail.nih.gov
Healthcare Delivery Research Clinical Trials
Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors PAR-19-018 R01 Clinical Trial Not Allowed March 5, 2021 Damali Martin
240-276-6746
martinda@mail.nih.gov
Health Disparities Not Clinical Trials
Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors PAR-19-019 R21 Clinical Trial Not Allowed March 5, 2021 Damali Martin
240-276-6746
martinda@mail.nih.gov
Health Disparities Not Clinical Trials
Academic Research Enhancement Award PA-18-504 Parent R15 January 8, 2021 Shobha Srinivasan
240-276-6938
ss688k@nih.gov
Health Disparities Not Clinical Trials
Administrative Supplements to Support Cancer Disparity Collaborative Research PA-18-842 Clinical Trial Optional September 11, 2020 Damali Martin
240-276-6746
martinda@mail.nih.gov
Health Disparities Clinical Trials
Intervention Research to Improve Native American Health PAR-17-496 R01 May 15, 2020 Shobha Srinivasan
240-276-6938
ss688k@nih.gov
Health Disparities Not Clinical Trials
Research to Improve Native American Health (R21 Clinical Trials Optional) PAR-17-464 R21 May 15, 2020 Shobha Srinivasan
240-276-6938
ss688k@nih.gov
Health Disparities Not Clinical Trials
Addressing Health Disparities through Effective Interventions Among Immigrant Populations PA-18-284 R01 Clinical Trial Optional January 8, 2020 Shobha Srinivasan
240-276-6938
ss688k@nih.gov
Health Disparities Clinical Trials
Addressing Health Disparities through Effective Interventions Among Immigrant Populations PA-18-285 R21 Clinical Trial Optional January 8, 2020 Shobha Srinivasan
240-276-6938
ss688k@nih.gov
Health Disparities Clinical Trials
Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers PAR-17-483 R21 December 5, 2019 Shobha Srinivasan
240-276-6938
ss688k@nih.gov
Health Disparities Not Clinical Trials
Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers PAR-17-484 R01 December 5, 2019 Shobha Srinivasan
240-276-6938
ss688k@nih.gov
Health Disparities Not Clinical Trials
Dissemination and Implementation Research in Health (Domestic and International Funding Opportunity) PAR-19-274 R01 Clinical Trial Optional May 8, 2022 Gila Neta
240-276-6785
netagil@mail.nih.gov

Cynthia A. Vinson
240-276-6745
cvinson@mail.nih.gov
Implementation Science Clinical Trials
Dissemination and Implementation Research in Health (Domestic and International Funding Opportunity) PAR-19-275 R21 Clinical Trial Optional May 8, 2022 Gila Neta
240-276-6785
netagil@mail.nih.gov

Cynthia A. Vinson
240-276-6745
cvinson@mail.nih.gov
Implementation Science Clinical Trials
Dissemination and Implementation Research in Health (Domestic and International Funding Opportunity) PAR-19-276 R03 May 8, 2022 Gila Neta
240-276-6785
netagil@mail.nih.gov

Cynthia A. Vinson
240-276-6745
cvinson@mail.nih.gov
Implementation Science Not Clinical Trials
Integration of Individual Residential Histories into Cancer Research PA-17-298 R01 September 8, 2020 Zaria Tatalovich
240-276-6976
tatalovichzp@mail.nih.gov
Surveillance Research Not Clinical Trials
Integration of Individual Residential Histories into Cancer Research PA-17-295 R21 September 8, 2020 Zaria Tatalovich
240-276-6976
tatalovichzp@mail.nih.gov
Surveillance Research Not Clinical Trials
Leveraging Population-based Cancer Registry Data to Study Health Disparities PA-17-289 R01 September 8, 2020 Nadia Howlader
240-276-6891
howladern@mail.nih.gov
Surveillance Research Not Clinical Trials
Leveraging Population-based Cancer Registry Data to Study Health Disparities PA-17-288 R21 September 8, 2020 Nadia Howlader
240-276-6891
howladern@mail.nih.gov
Surveillance Research Not Clinical Trials
Cancer Intervention and Surveillance Modeling Network (CISNET) RFA-CA-19-054 U01 Clinical Trial Not Allowed December 11, 2019

Eric (Rocky) Feuer
301-276-6772
feuerr@mail.nih.gov

Surveillance Research Not Clinical Trials
Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control PAR-20-034 R01 Clinical Trial Optional January 8, 2023 Rebecca Ferrer
301-852-1167
rebecca.ferrer@nih.gov
Basic Biobehavioral and Psychological Sciences Clinical Trials
Perception and Cognition Research to Inform Cancer Image Interpretation PAR-19-387 R01 Clinical Trial Optional January 8, 2023 Todd Horowitz
240-276-6963
horowitzts@mail.nih.gov
Basic Biobehavioral and Psychological Sciences Clinical Trials
Perception and Cognition Research to Inform Cancer Image Interpretation PAR-19-389 R21 Clinical Trial Optional January 8, 2023 Todd Horowitz
240-276-6963
horowitzts@mail.nih.gov
Basic Biobehavioral and Psychological Sciences Clinical Trials
Neural Regulation of Cancer PAR-19-353 R01 Clinical Trial Not Allowed May 28, 2022 Chamelli Jhappan
jhappanc@mail.nih.gov

Paige Green
240-276-6899
paige.green@nih.gov
Basic Biobehavioral and Psychological Sciences Not Clinical Trials
Neural Regulation of Cancer PAR-19-354 R21 Clinical Trial Not Allowed May 28, 2022 Chamelli Jhappan
jhappanc@mail.nih.gov

Paige Green
240-276-6899
paige.green@nih.gov
Basic Biobehavioral and Psychological Sciences Not Clinical Trials
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment PAR-19-340 R01 Clinical Trial Optional June 9, 2022 Todd Horowitz
240-276-6963
horowitzts@mail.nih.gov
Basic Biobehavioral and Psychological Sciences, Cancer Survivorship Clinical Trials
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment PAR-19-339 R21 Clinical Trial Optional June 9, 2022 Todd Horowitz
240-276-6963
horowitzts@mail.nih.gov
Basic Biobehavioral and Psychological Sciences, Cancer Survivorship Clinical Trials
Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery PA-18-004 R01 Clinical Trial Optional January 8, 2020 Wendy Nelson
240-276-6971
nelsonw@mail.nih.gov
Basic Biobehavioral and Psychological Sciences, Cancer Survivorship Clinical Trials
Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery PA-18-014 R21 Clinical Trial Optional January 8, 2020 Wendy Nelson
240-276-6971
nelsonw@mail.nih.gov
Basic Biobehavioral and Psychological Sciences, Cancer Survivorship Clinical Trials
Communication and Decision Making for Individuals with Inherited Cancer Syndromes RFA-CA-20-006 U01 Clinical Trial Optional January 22, 2020 Wendy Nelson
240-276-6971
nelsonw@mail.nih.gov
Basic Biobehavioral and Psychological Sciences Clinical Trials
Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control PAR-19-309 R21 Clinical Trial Optional September 8, 2022 Tanya Agurs-Collins
240-276-6956
collinsta@mail.nih.gov
Health Behaviors Research Clinical Trials
Nutrition and Alcohol-Related Health Outcomes PA-17-211 R01 May 8, 2020 Tanya Agurs-Collins
240-276-6956
collinsta@mail.nih.gov
Health Behaviors Research Not Clinical Trials
Nutrition and Alcohol-Related Health Outcomes NOT-CA-19-012 May 8, 2020 Tanya Agurs-Collins
240-276-6956
collinsta@mail.nih.gov
Health Behaviors Research Not Clinical Trials
Time-Sensitive Obesity Policy and Program Evaluation PAR-18-854 R01 September 11, 2021 David Berrigan
240-276-6752
David.Berrigan@nih.gov

Jill Reedy
240-276-6812
reedyj@mail.nih.gov
Health Behaviors Research Not Clinical Trials
Exploratory/Developmental Clinical Research Grants in Obesity PA-18-720 R21 Clinical Trial Optional May 8, 2021 Tanya Agurs-Collins
240-276-6956
collinsta@mail.nih.gov 
Health Behaviors Research Clinical Trials
Testing Interventions for Health-Enhancing Physical Activity PAR-18-324 R01 Clinical Trial Optional January 8, 2021 Frank Perna
240-276-6782
pernafm@mail.nih.gov
Health Behaviors Research Clinical Trials
Testing Interventions for Health-Enhancing Physical Activity PAR-18-307 R21/R33 Clinical Trial Optional January 8, 2021 Frank Perna
240-276-6782
pernafm@mail.nih.gov
Health Behaviors Research Clinical Trials
Smart and Connected Health (National Science Foundation – NIH Interagency Initiative) NOT-OD-13-041 R01 April Oh
240-276-6709
april.oh@nih.gov
Health Communication and Informatics Research Not Clinical Trials
End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness PA-18-498 R01 Clinical Trial Optional May 8, 2021 Sylvia Chou
240-276-6954
chouws@mail.nih.gov
Health Communication and Informatics Research, Cancer Survivorship Clinical Trials
End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness PA-18-499 R21 Clinical Trial Optional May 8, 2021 Sylvia Chou
240-276-6954
chouws@mail.nih.gov
Health Communication and Informatics Research, Cancer Survivorship Clinical Trials
Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Disparities PAR-19-093 R01 Clinical Trial Optional March 5, 2021 April Oh
240-276-6709
april.oh@nih.gov
Health Communication and Informatics Research Clinical Trials
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem PAR-19-348 R01 Clinical Trial Optional June 9, 2022 Kelly Blake
240-281-5934
kelly.blake@nih.gov
Health Communication and Informatics Research Clinical Trials
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem PAR-19-350 R21 Clinical Trial Optional June 9, 2022 Kelly Blake
240-281-5934
kelly.blake@nih.gov
Health Communication and Informatics Research Clinical Trials
Mechanism for Time-Sensitive Drug Abuse Research PAR-19-064 R21 Clinical Trial Optional November 9, 2021 Kelly Blake
240-281-5934
kelly.blake@nih.gov
Tobacco Control Research Clinical Trials
Mechanism for Time-Sensitive Drug Abuse Research NOT-CA-19-015 November 9, 2021 Kelly Blake
240-281-5934
kelly.blake@nih.gov
Tobacco Control Research Not Clinical Trials
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study PAR-19-162 R01 Clinical Trial Not Allowed September 8, 2021 Annette Kaufman
240-276-6706
kaufmana@mail.nih.gov
Tobacco Control Research Not Clinical Trials
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study PAR-19-163 R21 Clinical Trial Not Allowed September 8, 2021 Annette Kaufman
240-276-6706
kaufmana@mail.nih.gov
Tobacco Control Research Not Clinical Trials
Tobacco Regulatory Science RFA-OD-19-028 R01 Clinical Trial Optional February 14, 2021 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
Tobacco Control Research Clinical Trials
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services PAR-18-222 R01 Clinical Trial Optional November 14, 2020 Michele Bloch
240-276-6878
blochm@mail.nih.gov
Tobacco Control Research Clinical Trials
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services PAR-16-455 R01 November 14, 2020 Michele Bloch
240-276-6878
blochm@mail.nih.gov
Tobacco Control Research Not Clinical Trials
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research PAR-18-847 R01 Clinical Trial Optional June 28, 2020 For cancer-related FOA questions:
Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov

For general FOA questions:
Dionne Godette-Greer
Office of Disease Prevention (ODP)
301-480-1161
dionne.godette@nih.gov
Tobacco Control Research Clinical Trials
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research PAR-18-848 R21 Clinical Trial Optional June 28, 2020 For cancer-related FOA questions:
Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov

For general FOA questions:
Dionne Godette-Greer
Office of Disease Prevention (ODP)
301-480-1161
dionne.godette@nih.gov
Tobacco Control Research Clinical Trials
U.S. Tobacco Control Policies to Reduce Health Disparities PAR-18-675 R01 Clinical Trial Optional June 16, 2020 Bob Vollinger
240-276-6919
Bob.Vollinger@nih.gov

Annette Kaufman
240-276-6706
kaufmana@mail.nih.gov
Tobacco Control Research Clinical Trials
U.S. Tobacco Control Policies to Reduce Health Disparities PAR-18-674 R21 Clinical Trial Optional June 16, 2020 Bob Vollinger
240-276-6919
Bob.Vollinger@nih.gov

Annette Kaufman
240-276-6706
kaufmana@mail.nih.gov
Tobacco Control Research Clinical Trials
Availability of Administrative and Revision Supplements to Expand Vaping Research and Understand EVALI (Notice of Special Interest) NOT-HL-19-724 February 28, 2020 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
Tobacco Control Research
Tobacco Use and HIV in Low and Middle Income Countries PAR-18-023 R01 Clinical Trial Optional January 8, 2020 Mark Parascandola
240-276-6871
Mark.Parascandola@nih.gov
Tobacco Control Research Clinical Trials
Tobacco Use and HIV in Low and Middle Income Countries PAR-18-022 R21 Clinical Trial Optional January 8, 2020 Mark Parascandola
240-276-6871
Mark.Parascandola@nih.gov
Tobacco Control Research Clinical Trials
Integrative Research on Polysubstance Abuse and Addiction PAR-18-084 R21/R33 Clinical Trial Optional January 8, 2020 Michele Bloch
240-276-6878
blochm@mail.nih.gov
Tobacco Control Research Clinical Trials
Maximizing the Scientific Value of Existing Biospecimen Collections RFA-OD-19-021 R21 Clinical Trial Not Allowed March 9, 2021 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
Tobacco Control Research Not Clinical Trials
Secondary Analyses of Existing Datasets of Tobacco Use and Health RFA-OD-19-022 R21 Clinical Trial Not Allowed March 9, 2021 Rachel Grana Mayne
240-276-5899
rachel.mayne@nih.gov
Tobacco Control Research Not Clinical Trials

 

Go to the Archive of Funding Opportunities for information on recent funding announcements. Visit the Cancer Control Research section of this website for descriptive information on currently funded grants in this area.